A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone palmitate

Paliperidone palmitate will be administered im as an initial loading dose of 150 mg eq. on Day 1 and 100 mg eq. 1 week later in the deltoid muscle, and will be administered in a flexible dose range of 25 to 150 mg eq. at 4-week intervals from Week 5 for a total of 11 injections.

Trial Locations (29)

Unknown

Asahi

Fujioka

Fujisawa

Hachiōji

Higashimurayama

Hiroshima

Iizuka

Kanuma

Kashihara

Kashiwara

Kochi

Kure

Maebashi

Moriguchi

Nagasaki

Nirasaki

Ohta

Sapporo

Shimonoseki

Shinjyuku

Takatsuki

Tama

Tokushima

Tokyo

Ube

Ueda

Uji

Yokohama

Yokosuka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY